Medical Condition News

RSS

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States Food and Drug Administration has approved Sucampo's supplemental new drug application for AMITIZA (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

24 Apr 2013

BD receives FDA approval for second prefilled injectable drug

BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD, announced today that the U.S. Food and Drug Administration has approved the second drug to be offered in the recently launched BD Simplist line of ready-to-administer prefilled generic injectables.

From BD (Becton, Dickinson and Company) 24 Apr 2013

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

The Parkinson's Progression Markers Initiative, a landmark biomarker clinical study, has completed enrollment of its initial 600-member cohort of Parkinson's patients and controls, and will launch additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson's disease.

24 Apr 2013

Researchers uncover potential new way to fight obesity-related illness

A potential new way to fight obesity-related illness has been uncovered, thanks to serendipitous research led by investigators at the Case Western Reserve University School of Medicine.

24 Apr 2013

CNIO researcher-led consortium to receive MRA grant to advance research in melanoma

A consortium led by the Spanish National Cancer Research Centre's researcher Mar-a S. Soengas −Programme Director of the Centre-s Molecular Pathology Programme and Leader of the CNIO Melanoma Group− has been selected to receive funding from the Melanoma Research Alliance, the most important private international melanoma research foundation, in order to advance research in melanoma; this type of skin tumour represents one of oncology's biggest challenges due to its high incidence and malignancy.

24 Apr 2013

Therapy originally conceived for cancer could hold promise for weight loss, say researchers

Researchers have long known that cancerous tumors grow collections of abnormal blood cells, the fuel that feeds this disease and keeps it growing. Now, new evidence in an animal model suggests that blood vessels in the fat tissue of obese individuals could provide the same purpose-and could provide the key to a new way for people to lose weight.

24 Apr 2013

Frequent binge drinking in college increases risk of cardiovascular disease later in life

Frequent binge drinking in college can cause more than a hangover. Regularly consuming multiple drinks in a short window of time can cause immediate changes in circulation that increase an otherwise healthy young adult's risk of developing cardiovascular disease later in life, according to research published online today in the Journal of the American College of Cardiology.

24 Apr 2013

McGraw-Hill publishes preeminent textbook for pulmonary physiology in Lange Physiology Series

The 8th Edition of PULMONARY PHYSIOLOGY by Dr. Michael G. Levitzky, Professor of Physiology, Anesthesiology, and Cardiopulmonary Science at LSU Health Sciences Center New Orleans, was published this month by McGraw-Hill in its Lange Physiology Series.

24 Apr 2013

Whole eggs can be part of heart-healthy diet, say researchers

This week at Experimental Biology 2013, scientists from around the world are gathering to share research on a variety of topics, including nutrition and health. Given the growing global burden of chronic disease, there is particular interest in the important role of diet and nutrition in overall health.

24 Apr 2013

University of Leicester study investigates early detection of pancreatic cancer

Pioneering research to investigate whether pancreatic cancer can be detected early through a blood test is to be spearheaded by the University of Leicester thanks to new funding provided by Hope Against Cancer.

24 Apr 2013

Rheumatoid arthritis diagnosis: an interview with Dr. Stan Naides, Medical Director, Quest Diagnostics

Rheumatoid arthritis (RA) is an autoimmune disorder that can cause debilitating joint damage. In cases of RA, the immune system attacks the body’s own tissues, especially the membranes that line the joints. As a result, fluid builds up in the joints, causing pain and systemic inflammation, leading to joint destruction if untreated.

From Quest Diagnostics 23 Apr 2013

$Fracture liaison systems help reduce burden of fragility fractures$

Fracture liaison systems help reduce burden of fragility fractures

Fragility fractures due to osteoporosis are a major cause of disability or premature death in older adults. Those at highest risk are patients who have already suffered one fragility fracture; they are at twice the risk of suffering a future fracture compared to others who have not fractured.

23 Apr 2013

Study: Stressful situations at work can have negative impact on cardiovascular system and metabolism

Stressful situations at work can have a negative impact on the cardiovascular system and the metabolism. Stress, which is transmitted by direct and indirect signaling pathways, leads to an inflammatory response in the body, which can trigger cardiovascular diseases, amongst others.

23 Apr 2013

Study shows intraventricular chemotherapy increases overall survival in LMC patients

Lung cancer is one of the most common primary cancers that cause leptomeningeal carcinomatosis (LMC), when cancer spreads to the membranes surrounding the spinal cord and brain. Cases of LMC have increased because of the improved survival of lung cancer patients with the help of new advances in treatment.

23 Apr 2013

Study suggests lung cancer patients with HER2 mutations may benefit from anti-HER2 drugs

New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced non-small cell lung cancer (NSCLC) harboring specific HER2 protein mutations.

23 Apr 2013

Medical Condition News

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

BD receives FDA approval for second prefilled injectable drug

PPMI to launch additional study to evaluate multiple potential biomarkers for Parkinson's disease

Researchers uncover potential new way to fight obesity-related illness

CNIO researcher-led consortium to receive MRA grant to advance research in melanoma

Therapy originally conceived for cancer could hold promise for weight loss, say researchers

Frequent binge drinking in college increases risk of cardiovascular disease later in life

McGraw-Hill publishes preeminent textbook for pulmonary physiology in Lange Physiology Series

Whole eggs can be part of heart-healthy diet, say researchers

University of Leicester study investigates early detection of pancreatic cancer

Rheumatoid arthritis diagnosis: an interview with Dr. Stan Naides, Medical Director, Quest Diagnostics

Fracture liaison systems help reduce burden of fragility fractures

Study: Stressful situations at work can have negative impact on cardiovascular system and metabolism

Study shows intraventricular chemotherapy increases overall survival in LMC patients

Study suggests lung cancer patients with HER2 mutations may benefit from anti-HER2 drugs

Individual cancer cells in blood stream are responsible for metastases in breast cancer patients

iQBS researchers discover three unique genetic variations that influence body size, obesity in African ancestry

Palliative radiotherapy for bone metastases can improve quality of life in elderly patients

Animal models of Huntington's disease allow better insights into disease's genetics

BTS launches belt to prevent lower back pain problems

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News